
Science Resources RSS Feeds
|
 |
 |
 |
University of the Basque Country study on proteins related to Alzheimer
October 16, 2009
The cause, or at least one of the possible causes, of memory loss amongst Alzheimer sufferers is related to the location of certain proteins. The aim of this University of the Basque Country (UPV/EHU) PhD thesis was to analyse the location of certain proteins related to Alzheimer's. The author of the thesis was Ms Naroa Anabitarte Gonzalez and her work is entitled, Alzheimer gaixotasunarekin erlazionatutako proteinen ultraegitura mailako kokapena baldintza fisiologikoetan: APP eta PS1 arratoi helduen hipokanpoan (Ultrastructural location of the proteins related to Alzheimer's disease: APP and PS1 in the hyperfield of mature rats).
A number of studies were undertaken on the proteolysis of the APP protein and on the location of this process in the interior of the cell. It is not yet very clear where this proteolysis or rupture occurs. In this vein, with the help of an electronic microscope, Ms Anabitarte studied the location of the proteins related to Alzheimer's disease (APP and PS1) in the region of the plasma membrane
To this end, she employed a number of antibodies capable of recognising fragments of APP protein. She also used another antibody in order to analyse the location of the PS1 protein. According to the results, both are found in large concentrations in the membranes of the synapses. These results coincide with those from the other groups, given that they situate the APP and PS1 proteins in the synapses. Synapses are involved in the process of communication between neurones. Synaptic plasticity is the property arising from the nature and functioning of neurones when these make communication with each other. All memory and learning processes are based on the mentioned property. In order for synaptic plasticity to occur, a number of molecules have to participate, and the APP protein is one of the most important. To this end, it is important to know how and when the rupture or proteolysis of this protein occurs.
Depending on the enzymes taking part in the proteolysis of the APP protein, different fragments are formed. One of the most important enzymes taking part in this process is Presenilin-1 (PS1). The fragments formed have different functions and some of these may have deleterious consequences. Thus, according to the author of the thesis, it is of utmost importance to know how proteolysis occurs, given that this is directly related to Alzheimer's disease.
Elhuyar Fundazioa
|
 |

|
Pharmacogenomics in Drug Discovery and Development (Methods in Molecular Biology)
by Qing Yan (Editor)
Since each human is genetically distinctive, responding differently to disease-causing factors as well as drugs, the field pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In Pharmacogenomics in Drug Discovery and Development, leading experts present methodical, state-of-the-art contributions covering topics from individual molecules to systemic diseases, examining both fundamental concepts and advanced technologies. Divided into three sections, the volume begins by exploring cutting-edge technologies used to pursue systems-based pharmacogenomics, followed by extensive chapters on gene-drug interactions and the use of pharmacogenomics in therapeutics of diseases. Comprehensive and up-to-date, Pharmacogenomics...
|

|
New Science of Alzheimer's Disease / TIME Cover: July 17, 2000, Framed Art Print by TIME Magazine
by barewalls
The most eagerly awaited event in the editorial cycle at TIME Magazine is always the selection of the cover. The best covers capture the zeitgeist of the week while surviving the judgment of history. As browsing this collection of TIME cover art prints shows, TIME is as good a record as any of who and what mattered over the past 80-plus years. And so when TIME captures a person, an event or a trend within its iconic red borders, the magazine is adding that extra dose of significance that no other publication can quite match. That is one reason why the original artwork for more than 800 TIME covers now resides in the National Portrait Gallery in Washington. Thanks to an amazing roster of artists, photographers and graphic designers, from TIME's earliest charcoal drawings of cover subjects...
|

|
The Forgetting - A Portrait of Alzheimer's
Starring: David Hyde Pierce Directed By: Elizabeth Arledge Also With: Elizabeth Arledge (Producer), Doug Quade (Editor), Naomi S. Boak (Producer), Whitney Johnson (Producer)
Studio: Paramount Home Video Release Date: 11/01/2005
|
|
|
Alzheimer’s Disease Chart
by American 3B Scientific
Alzheimer’s Disease Chart Alzheimer’s Disease ChartThis thickly laminated anatomical chart is printed on premium glossy (200 g) UV resistant paper and comes with 2 sided lamination (125 micron, 5.0 Mil) and metal eyelets to make the chart easy to display. It comes in a convenient poster size 50 x 67 cm (20x26’’) and can be written on and wiped off with non permenant markers. The 125 micron lamination ensures the chart does not curl up at the edges and the UV treament ensures the chart does not get a faded yellow color over time.Measurements:50 x 67 cm Weight: 0,15 kgProduct photo may not exactly match the product offered for sale. Please refer to the product description.
|

|
Alzheimer's Disease: A Wilderness Exposed (NCME Video S103)
Also With: Network For Continuing Medical Education (Primary Contributor), Kenneth L. David (Primary Contributor), Allen D. Roses (Primary Contributor), Dennis J. Selkoe (Primary Contributor), Rudolph E. Tanzi (Primary Contributor)
|

|
Natrol Extra Strength ENADA NADH, 5 mg, MicroTablets - 30 ea
by Natrol
The Energizing CoEnzyme. A Patented Formula. The Only Stable NADH. Maximum Bioavailability. Dietary Supplement. Natrol® Enada®'s NADH is a patented dietary ingredient designed for those whose active lifestyles demand the very best. As a coenzyme, NADH plays a key role in the energy production of our cells and neurotransmitter processes.* Natrol offers Enada's NADH - the only stable form of NADH in the marketplace today. This exclusive patented supplement assures maximum bioavailability. *The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent disease. If you have or suspect a medical condition, consult your healthcare professional prior to use. NADH (Vegetable source) (reduced 5 nicotinamide...
|

|
A Guide to the Spiritual Dimension of Care for People With Alzheimer s Disease and Related Dementia: More Than Body, Brain, and Breath
by Eileen Shamy (Author)
In this sensitive and informative book, Eileen Shamy, a pioneer of ministry to people with Alzheimer's disease, discusses how pastoral work can help to develop holistic care for those suffering from dementia and related conditions - care which involves understanding of their spiritual as well as physical needs. From her years of experience as a clergywoman working with older people in care settings, the author provides guidelines for pastoral visits to people with dementia, showing how to empathise with, understand and support individuals during a visit. She discusses what constitutes spiritual well-being in individuals and suggests ways in which this can be nurtured. Emphasising the importance of retaining dignity and freedom of choice for people with dementia, she also presents...
|

|
The Inflammation Pathway from Cholesterol to Aging - Medications and Plants that prevent and treat Aging, Cardiovascular Disease, Osteoporosis, Arthritis, Type-2 Diabetes, Dementia and Alzheimers disease
by Sota Omoigui MD (Author)
|

|
Mayo Clinic on Alzheimers Disease
by M.D., Ph.D. Ronald Petersen (Editor)
|
|
|
Alzheimer's s Disease: An Overview.: An article from: Southern Medical Journal
by Ronald C. Hamdy (Author)
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on July 1, 2001. The length of the article is 1102 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Alzheimer's s Disease: An Overview. Author: Ronald C. Hamdy Publication: Southern Medical Journal (Refereed) Date: July 1, 2001 Publisher: Southern Medical Association Volume: 94 Issue: 7 Page: 661
Distributed by Thomson...
|
|